Sign In
Buy FLDM
$1.83
+0 (+0%)
At Close: Jul 20, 2022
Fluidigm COVID-19 Funding, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:FLDM)
12:03pm, Monday, 03'rd Aug 2020
Fluidigm receives NIH funding for COVID-19 testing technology. Stereotaxis receives positive fillip from first integrated cardiac ablation procedure.
The Global Digital PCR Market will grow by USD 252.26 mn during 2020-2024
Here's Why Fluidigm Soared as Much as 58.6% Today
07:11pm, Friday, 31'st Jul 2020
The struggling laboratory hardware developer received a $37 million infusion to tackle the coronavirus pandemic.
NIH Awards Grants to Medical Companies to Boost Coronavirus Test Production
06:52pm, Friday, 31'st Jul 2020
The National Institutes of Health awarded $249 million in grants to seven companies making new coronavirus diagnostic technology in a move aimed at producing millions more tests per week to alleviate
Coronavirus update: Fauci, CDC face Congress as US coronavirus cases spiral higher
05:41pm, Friday, 31'st Jul 2020
The U.S.’s troubled response to the coronavirus pandemic was on display Friday, as the Trump Administration’s top health officials testified before Congress, warning that the virus’ spread would
Fluidigm Selected for $37 Million Project under National Institutes of Health RADx Initiative
03:10pm, Friday, 31'st Jul 2020
Fluidigm among First Seven Companies to Advance in Historic and Rapidly Instituted Program to Support Development and Commercialization of Innovative COVID-19 Testing TechnologiesSOUTH SAN FRANCISCO,
Analysts Estimate Fluidigm (FLDM) to Report a Decline in Earnings: What to Look Out for
04:33pm, Thursday, 30'th Jul 2020
Fluidigm (FLDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fluidigm (NASDAQ:FLDM) Stock Crosses Above Two Hundred Day Moving Average of $3.59
03:14am, Wednesday, 22'nd Jul 2020
Fluidigm Co. (NASDAQ:FLDM) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $3.59 and traded as high as $6.51. Fluidigm shares last
Test Intended to Expand Availability of COVID-19 Screening Resources in Central Ohio Workflow with Real-Time PCR Using Fluidigm Microfluidics Technology and Reagents.
How Should Investors Feel About Fluidigm's (NASDAQ:FLDM) CEO Remuneration?
05:34pm, Wednesday, 15'th Jul 2020
This article will reflect on the compensation paid to Chris Linthwaite who has served as CEO of Fluidigm Corporation...
Merck : Changes in Merck KGaA, Darmstadt, Germany, Executive Board | MarketScreener
01:06pm, Monday, 13'th Jul 20203 Small-Cap Stocks Under $6 That Could See Over 70% Gains
01:42pm, Thursday, 09'th Jul 2020
As the number of new COVID-19 cases climbs at a record pace, the stock market isn’t just trudging along, it’s charging forward. Given this clear disconnect, finding compelling plays can feel like
Fluidigm Announces Conference Call and Webcast of Second Quarter 2020 Financial Results
08:02pm, Monday, 06'th Jul 2020
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today
5 Stocks To Watch In Biotech, Space And Manufacturing
12:00am, Thursday, 02'nd Jul 2020
Stocks Analysis by Harry Boxer covering: YRC Worldwide Inc, Amgen Inc, Ballard Power Systems Inc, Tesla Inc. Read Harry Boxer's latest article on Investing.com
